LifeSource-Upper Midwest OPO, Minneapolis, MN – FDA Inspections

Inspection records and compliance data for LifeSource-Upper Midwest OPO in Minneapolis, Minnesota. 7 FDA inspections on record, last inspected July 30, 2025.

Company Profile

This profile covers LifeSource-Upper Midwest OPO based in Minneapolis, Minnesota, United States.

FDA Inspection History

FDA inspections: 7
OAI: 0
VAI: 1
NAI: 5
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected May 21, 2010. Last inspected July 30, 2025.

Most cited issue areas

Accurate, indelible, legible1 inspection
All core requirements covered in program1 inspection
Procedures to meet core CTGP1 inspection

FDA inspections (7)

Date	Result	FDA center(s)	Insp. #
July 30, 2025	Not classified	Biologics	1279132
March 22, 2019	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	1084827
September 20, 2017	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	1028803
February 9, 2015	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	913084
October 24, 2012	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	805924
January 24, 2012	VAI	Biologics · Human Cellular, Tissue, and Gene Therapies	758993
May 21, 2010	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	666938

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

BioLife Plasma Services LP

Mayo Clinic Rochester, Division of Transfusion Medicine

BioLife Plasma Services L.P.

Carris Health, LLC

Secure Transfusion Solutions, Inc.

M Health Fairview University of Minnesota Medical Center, West Bank -Blood Bank

Innovative Blood Resources, a Division of New York Blood Center, Inc., DBA Memorial Blood Centers

Rice, Kathryn L., MD, Clinical Investigator

Alexander Khoruts, M.D., Sponsor-Investigator

Cuyuna Regional Medical Center